|Last Price$73.65||Day Change (%)0.81%|
|Open Price$73.23||Day Change ($)0.59|
|Day Range73.05–73.71||52-Week Range59.20–79.37|
As of Fri 10/24/2014 03:39 PM EST | USD
Pharmacy benefits manager Express Scripts is attractively priced given its ability to fend off competitors for years to come.
HITRUST and Healthcare Leaders Collaborate to Establish Cyber Threat XChange to Improve and Accelerate Cyber Threat Detection and Response
Walgreens Expands Preferred Network Relationships to Nine National Medicare Part D Plan Sponsors
Investors concerned with Express Scripts' integration of Medco are overlooking the firm's long-term potential to benefit from an increased focus on health-care cost-cutting, says Morningstar StockInvestor editor Matt Coffina.
Misunderstanding on private health insurance exchanges could mean opportunity for investors.
While the sector looks fairly valued overall, we still see several stocks that offer attractive valuations across the different industries, including pharmacy benefit managers.
Express Scripts ESRX reported first-quarter results that beat our expectations. The company also increased its earnings-per-share guidance for the year, but more importantly to us, Express Scripts expects higher cash flow from operations in 2007 than it did previously. We're reviewing our model in ...
In a fully valued market, there are worse things than buying wide-moat names at decent discounts.
We believe its acquisition strategy puts the PBM on the right course.